-
Founded in:
1981-12-14 -
Country:
China -
Address:
No. 2, Rongyang 1st Road, Xishan Economic and Technological Development Zone, Wuxi City -
Tax NO.:
91320205135902394F -
Registered Funds:
581 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sisomycin Sulfate |
No specific description provided
More
No specific description provided |
53179-09-2 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Vitamin E |
Participate in some metabolic reactions in the body, fight against the peroxidation of free radicals, protect the skin, increase ovarian function, and prevent habitual abortion.
More
Participate in some metabolic reactions in the body, fight against the peroxidation of free radicals, protect the skin, increase ovarian function, and prevent habitual abortion. |
100mg | 2074-53-5 | 11 |
| Ascorbic Acid |
Participate in the formation of antibodies, collagen and tissue repair in the body, as well as the metabolism of carbohydrates, fats and proteins, maintain the integrity of blood vessels and increase the body's resistance
More
Participate in the formation of antibodies, collagen and tissue repair in the body, as well as the metabolism of carbohydrates, fats and proteins, maintain the integrity of blood vessels and increase the body's resistance |
200mg | 50-81-7 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| SPIRAMYCIN BASE |
Macrolide antibiotics inhibit microbial protein synthesis, have antibacterial effects on Gram-positive bacteria and some Gram-negative bacteria, and also have certain effects on Toxoplasma gondii, Ureaplasma urealyticum, and Cryptosporidium.
More
Macrolide antibiotics inhibit microbial protein synthesis, have antibacterial effects on Gram-positive bacteria and some Gram-negative bacteria, and also have certain effects on Toxoplasma gondii, Ureaplasma urealyticum, and Cryptosporidium. |
0 | ||
| SPIRAMYCIN BASE |
Macrolide antibiotics inhibit microbial protein synthesis, have antibacterial effects on Gram-positive bacteria and some Gram-negative bacteria, and also have certain effects on Toxoplasma gondii, Ureaplasma urealyticum, and Cryptosporidium.
More
Macrolide antibiotics inhibit microbial protein synthesis, have antibacterial effects on Gram-positive bacteria and some Gram-negative bacteria, and also have certain effects on Toxoplasma gondii, Ureaplasma urealyticum, and Cryptosporidium. |
0 | ||
| Spiramycin |
Macrolide antibiotics inhibit microbial protein synthesis, have antibacterial effects on Gram-positive bacteria and some Gram-negative bacteria, and also have certain effects on Toxoplasma gondii, Ureaplasma urealyticum, and Cryptosporidium.
More
Macrolide antibiotics inhibit microbial protein synthesis, have antibacterial effects on Gram-positive bacteria and some Gram-negative bacteria, and also have certain effects on Toxoplasma gondii, Ureaplasma urealyticum, and Cryptosporidium. |
8025-81-8 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lactic acid |
Pharmacological action not specified
More
Pharmacological action not specified |
50-21-5 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium lactate |
Under normal circumstances, the human body contains a small amount of lactic acid in the blood, which is mainly produced by glucose or glycogenolysis in tissues such as muscles, skin, brain and cells. After lactic acid is produced, it is either converted into glycogen or pyruvate, or enters the tricarboxylic acid cycle and is decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can be used to correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from the blood and extracellular fluid. The main organs for lactic acid degradation are the liver and kidneys. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor; in addition, the effect of sodium lactate is not as rapid as that of sodium bicarbonate.
More
Under normal circumstances, the human body contains a small amount of lactic acid in the blood, which is mainly produced by glucose or glycogenolysis in tissues such as muscles, skin, brain and cells. After lactic acid is produced, it is either converted into glycogen or pyruvate, or enters the tricarboxylic acid cycle and is decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can be used to correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from the blood and extracellular fluid. The main organs for lactic acid degradation are the liver and kidneys. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor; in addition, the effect of sodium lactate is not as rapid as that of sodium bicarbonate. |
312-85-6 | 0 |